These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 856727

  • 21. [In vitro activity of cefoxitin, a new cephalosporin (author's transl)].
    Shah PM, Zwischenbrugger H, Stille W.
    MMW Munch Med Wochenschr; 1976 Nov 05; 118(45):1469-72. PubMed ID: 825763
    [Abstract] [Full Text] [Related]

  • 22. Variations in susceptibility to latamoxef(moxalactam) and cefoxitin within the Bacteroides fragilis group.
    Eley A, Greenwood D.
    J Antimicrob Chemother; 1984 Mar 05; 13(3):245-55. PubMed ID: 6725175
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Cefoxitin resistance to beta-lactamase: a major factor for susceptibility of bacteroides fragilis to the antibiotic.
    Darland G, Birnbaum J.
    Antimicrob Agents Chemother; 1977 Apr 05; 11(4):725-34. PubMed ID: 856025
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Induction of beta-lactamase production in the anaerobic microflora by cefoxitin.
    Stark C, Edlund C, Hedberg M, Nord CE.
    Clin Infect Dis; 1995 Jun 05; 20 Suppl 2():S350-1. PubMed ID: 7548595
    [No Abstract] [Full Text] [Related]

  • 29. Penetration of cephalothin and cefoxitin into experimental infections with Bacteroides fragilis.
    O'Keefe JP, Tally FP, Barza M, Gorbach SL.
    Rev Infect Dis; 1979 Jun 05; 1(1):106-12. PubMed ID: 318211
    [Abstract] [Full Text] [Related]

  • 30. Comparative in vitro activity of cefoxitin, cefotaxime alone, and in combination with desacetylcefotaxime against the Bacteroides species.
    Canawati HN.
    Diagn Microbiol Infect Dis; 1989 Jun 05; 12(1):33-7. PubMed ID: 2714070
    [Abstract] [Full Text] [Related]

  • 31. In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin.
    Eickhoff TC, Ehret JM.
    Antimicrob Agents Chemother; 1976 Jun 05; 9(6):994-9. PubMed ID: 938029
    [Abstract] [Full Text] [Related]

  • 32. Synergistic activity of cefsulodin combined with cefoxitin and sulbactam against Bacteroides species.
    Fu KP, Kimble EF, Zoganas H, Konopka EA.
    J Antimicrob Chemother; 1984 Mar 05; 13(3):257-65. PubMed ID: 6327598
    [Abstract] [Full Text] [Related]

  • 33. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II.
    J Infect Dis; 1978 May 05; 137 Suppl():S32-S37. PubMed ID: 349096
    [Abstract] [Full Text] [Related]

  • 34. Comparison of cefoxitin and cephalothin therapy of a mixed Bacteroides fragilis and Fusobacterius necrophorum infection in mice.
    Hackman AS, Wilkins TD.
    Antimicrob Agents Chemother; 1975 Aug 05; 8(2):224-5. PubMed ID: 1180547
    [Abstract] [Full Text] [Related]

  • 35. Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs.
    Sutter VL, Finegold SM.
    J Infect Dis; 1975 Apr 05; 131(4):417-22. PubMed ID: 804023
    [Abstract] [Full Text] [Related]

  • 36. Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines.
    Barry AL, Jones RN, Thornsberry C.
    Am J Clin Pathol; 1983 Aug 05; 80(2):182-9. PubMed ID: 6881092
    [Abstract] [Full Text] [Related]

  • 37. Comparison of three methods of susceptibility testing of bacteroidaceae, peptococcaceae and other anaerobes to doxycycline.
    Werner H, Krasemann C, Rodermund OE, Ungerechts J, Schneider B, Wilhelm J.
    Zentralbl Bakteriol Orig A; 1979 Sep 05; 244(4):525-34. PubMed ID: 543353
    [Abstract] [Full Text] [Related]

  • 38. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
    Goering RV, Sanders CC, Sanders W.
    J Antibiot (Tokyo); 1978 Apr 05; 31(4):363-72. PubMed ID: 306989
    [Abstract] [Full Text] [Related]

  • 39. Susceptibility of clinical isolates of bacteria to cefoxitin and cephalothin.
    Moellering RC, Dray M, Kunz LJ.
    Antimicrob Agents Chemother; 1974 Sep 05; 6(3):320-3. PubMed ID: 15830480
    [Abstract] [Full Text] [Related]

  • 40. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].
    Thabaut A, Durosoir JL, Saliou P.
    Pathol Biol (Paris); 1979 Dec 05; 27(10):649-54. PubMed ID: 395496
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.